2020 Valve General Flashcards

1
Q

STS Median Operative Mortality (2019)

MVr + CABG:

A

STS Median Operative Mortality (2019)

MVr + CABG: 5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Stage A Valvular heart disease

A

Patients At risk: Patients with risk factors for the development of VHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is considered evidence of significant gastrointestinal dysfunction for the establishment of surgical risk?

A

gastrointestinal dysfunction

  1. Crohn’s disease
  2. ulcerative colitis
  3. nutritional impairment
  4. serum albumin <3.0
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are considered significant neurological organ system dysfunction in the establishment of surgical risk ?

A

central nervous system dysfunction

  1. dementia,
  2. Alzheimer’s disease
  3. Parkinson’s disease
  4. a cerebrovascular accident with persistent physical limitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Criteria for LOW surgical risk for Mitral Repair

A

All of the below :

STS Risk of Death: < 1% Mortality

Frailty : None

Other Organ System failure Not to be improved post operatively : None

Procedure specific Impediments: None

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Criteria for Prohibitive Surgical risk

A

Any of the below :

  • STS Risk of Death: > 50% Mortality or
  • Frailty : >= 2 or
  • Other Organ System failure Not to be improved postoperatively: >= 3 or
  • Severe Procedure specific Impediments.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ACC/AHA Guidelines for futility

A

STS score >15

Life expectancy <1 y

Poor candidate for rehabilitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Stage B Valvular heart disease

A

B:

  • Progressive VHD:
  • Patients with progressive VHD (mild to moderate severity and asymptomatic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what organ systems are considered in establishing risk factors for valve surgery?

A
  1. cardiac dysfunction
  2. kidney dysfunction
  3. pulmonary dysfunction
  4. central nervous system dysfunction
  5. gastrointestinal dysfunction
  6. cancer (active malignancy);
  7. liver dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Utility of TEE

A

Provides high-quality assessment of:

mitral and prosthetic valve,

including a definition of intracardiac masses and possible associated abnormalities (eg, intracardiac abscess, LA thrombus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2019 Median operative mortality STS Database for AVR + CABG

A

4%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What Patients should Get A/C for atrial fibrillation

A

VHD and AF (not rheumatic MS or mech )

  • the decision VKA or non-VKA based on
  • CHA2DS2-VASc score.

Patients with rheumatic mitral stenosis or a mechanical prosthesis and atrial fibrillation

  • should receive oral anticoagulation with a vitamin K antagonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are considered significant Renal dysfunction for the establishment of surgical risk?

A

kidney dysfunction:

chronic kidney disease, stage 3 or worse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

STS Median Operative Mortality (2019)

AVR + MVR:

A

STS Median Operative Mortality (2019)

AVR + MVR: 9%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What procedures require abx prophylaxis

A

Procedures requiring Prophylaxis:

  • Dental procedures that involve:
    1. manipulation of the gingival tissue,
    2. periapical region of the teeth,
    3. perforation of the oral mucosa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

General indications for a mitraclip

A
  1. to patients with severely symptomatic primary mitral regurgitation who are at high or prohibitive risk for surgery
  2. a select subset of patients with secondary mitral regurgitation who remain severely symptomatic despite guideline-directed management and therapy for heart failure.
17
Q

2019 Median operative mortality STS Database for AVR

A

2.2 %

18
Q

STS Median Operative Mortality (2019)

MVr:

A

STS Median Operative Mortality (2019)

MVr: 1%

19
Q

What are considered evidence of significant hepatic dysfunction in the establishment of surgical risk for VHD ?

A
  1. history of cirrhosis
  2. variceal bleeding
  3. or elevated INR in the absence of VKA therapy
20
Q

General criteria upon which surgical risk is based

A
  1. STS Risk of Death
  2. Frailty
  3. Other Organ System failure Not to be improved postoperatively
  4. Procedure specific Impediments
21
Q

STS Median Operative Mortality (2019)

MVR+CABG:

A

STS Median Operative Mortality (2019)

MVR+CABG: 9%

22
Q

what are considered significant Cardiac Risk factors for valve intervention?

A
  1. severe LV systolic or diastolic dysfunction
  2. RV dysfunction
  3. fixed pulmonary hypertension
23
Q

STS Median Operative Mortality (2019)

MVR:

A

STS Median Operative Mortality (2019)

MVR: 5%

24
Q

Utility of PET CT

A

Aids in the determination of active infection or inflammation

25
Q

Criteria for the establishment of high surgical risk?

A

High Surgical risk

Any of the below :

STS Risk of Death: > 8% Mortality or

Frailty : >= 2 or

Other Organ System failure Not to be improved post operatively : 1-2 or

Procedure specific Impediments: Possible

26
Q

Criteria for Low Surgical risk for AVR

A

ALL of the below :

  • STS Risk of Death: < 3% Mortality
  • Frailty : None
  • Other Organ System failure Not to be improved post operatively : None
  • Procedure specific Impediments: None
27
Q

How many organ system dysfunctions must be present for high surgical risk ?

A

Other Organ System failure Not to be improved post operatively : 1-2

28
Q

Stage C Valvular Heart Disease

A

C: Asymptomatic severe Asymptomatic patients who have the criteria for severe VHD:

  • C1: Asymptomatic patients with severe VHD in whom the LV or RV remains compensated.
  • C2: Asymptomatic patients with severe VHD with decompensation of the LV or RV.